Innoviva Inc (NASDAQ:INVA)

14.46
Delayed Data
As of 4:00pm ET
 -0.19 / -1.30%
Today’s Change
11.02
Today|||52-Week Range
17.99
+1.90%
Year-to-Date
No recent news for Innoviva Inc.

Today’s Trading

Previous close14.65
Today’s open14.58
Day’s range14.12 - 14.78
Volume2,121,673
Average volume (3 months)993,855
Market cap$1.7B
Data as of 4:00pm ET, 04/26/2018

Growth & Valuation

Earnings growth (last year)+120.75%
Earnings growth (this year)+71.19%
Earnings growth (next 5 years)+23.03%
Revenue growth (last year)+56.75%
P/E ratio12.4
Price/Sales7.36
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PCRXPacira Pharmaceutica...-0.05-0.14%
EBSEmergent BioSolution...-0.08-0.15%
LXRXLexicon Pharmaceutic...-0.26-3.23%
IPXLImpax Laboratories I...-0.40-2.08%
Data as of 4:02pm ET, 04/26/2018

Financials

Last reporting dateApril 26, 2018
EPS forecast (this quarter)$0.53
Annual revenue (last year)$231.0M
Annual profit (last year)$134.1M
Net profit margin58.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
CEO, Chief Financial Officer &
Senior VP
Eric d'Esparbes
Chief Scientific Officer &
Senior Vice President
Theodore J. Witek
Corporate headquarters
Brisbane, California

Forecasts